Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain

Vaccine

Volumn 26, Issue 52, 2008, Pages 6965-6974

  Droebner, Karoline ^a   Haasbach, Emanuel ^a   Fuchs, Cordula ^b   Weinzierl, Andreas O ^c   Stevanovic, Stefan ^c   Büttner, Mathias ^b   Planz, Oliver ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b Bavarian Health and Food Safety Authority   (Germany)

^c Institute for Cell Biology   (Germany)

Author keywords

Cross protection; H5N1 influenza virus; Vaccine strategy

Indexed keywords

ANTIBODY; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CROSS REACTIONS; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY, CELLULAR; IMMUNOCOMPETENCE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA VACCINES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PLAQUE ASSAY; RESPIRATORY SYSTEM; VACCINATION;

EID: 56649102192     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.051     Document Type: Article

References (43)

1. Webby R.J., and Webster R.G. Are we ready for pandemic influenza?. Science 302 November (5650) (2003) 1519-1522
2. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solórzano A., Pappas C., et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 February (5812) (2007) 655-659
3. Cox R.J., Brokstad K.A., and Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59 January (1) (2004) 1-15
4. Fiers W., De F.M., Birkett A., Neirynck S., and Min J.W. A "universal" human influenza A vaccine. Virus Res 103 July (1-2) (2004) 173-176
5. De Filette M., Min J.W., Birkett A., Lyons K., Schultz B., Tonkyro A., et al. Universal influenza A vaccine: optimization of M2-based constructs. Virology 337 June (1) (2005) 149-161
6. Saha S., Yoshida S., Ohba K., Matsui K., Matsuda T., Takeshita F., et al. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology 354 October (1) (2006) 48-57
7. Lu X., Edwards L.E., Desheva J.A., Nguyen D.C., Rekstin A., Stephenson I., et al. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine 24 November (44-46) (2006) 6588-6593
8. Lipatov A.S., Hoffmann E., Salomon R., Yen H.L., and Webster R.G. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis 194 October (8) (2006) 1040-1043
9. Suguitan Jr. A.L., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 3 September (9) (2006) e360
10. Carrat F., and Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25 September (39-40) (2007) 6852-6862
11. Doherty P.C., Topham D.J., Tripp R.A., Cardin R.D., Brooks J.W., and Stevenson P.G. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159 October (1997) 105-117
12. Gerhard W. The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 260 (2001) 171-190
13. Lee B.O., Rangel-Moreno J., Moyron-Quiroz J.E., Hartson L., Makris M., Sprague F., et al. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol 175 November (9) (2005) 5827-5838
14. Townsend A.R., Rothbard J., Gotch F.M., Bahadur G., Wraith D., and McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44 March (6) (1986) 959-968
15. Scherle P.A., Palladino G., and Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 148 January (1) (1992) 212-217
16. Lawson C.M., Bennink J.R., Restifo N.P., Yewdell J.W., and Murphy B.R. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J Virol 68 June (6) (1994) 3505-3511
17. Yewdell J.W., Bennink J.R., Smith G.L., and Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 82 March (6) (1985) 1785-1789
18. Rimmelzwaan G.F., Fouchier R.A., and Osterhaus A.D. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr Opin Biotechnol 18 December (6) (2007) 529-536
19. Kreijtz J., de Mutsert G., van Baalen B.C., Fouchier R., Osterhaus A., and Rimmelzwaan G. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T lymphocyte populations directed to human influenza A virus. J Virol 82 June (11) (2008) 5161-5166
20. Matrosovich M., Matrosovich T., Garten W., and Klenk H.D. New low-viscosity overlay medium for viral plaque assays. Virol J 3 (2006) 63
21. Sakabe S., Sakoda Y., Haraguchi Y., Isoda N., Soda K., Takakuwa H., et al. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens. Vaccine 26 April (17) (2008) 2127-2134
22. Thomas P.G., Keating R., Hulse-Post D.J., and Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 12 January (1) (2006) 48-54
23. Thomas P.G., Brown S.A., Yue W., So J., Webby R.J., and Doherty P.C. An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc Natl Acad Sci USA 103 February (8) (2006) 2764-2769
24. Marangon S., Cecchinato M., and Capua I. Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 55 1 (2008) 65-72
25. Rinder M., Lang V., Fuchs C., Hafner-Marx A., Bogner K.H., Neubauer A., et al. Genetic evidence for multi-event imports of avian influenza virus A (H5N1) into Bavaria, Germany. J Vet Diagn Invest 19 May (3) (2007) 279-282
26. Sangster M.Y., Riberdy J.M., Gonzalez M., Topham D.J., Baumgarth N., and Doherty P.C. An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J Exp Med 198 October (7) (2003) 1011-1021
27. Scherle P.A., and Gerhard W. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med 164 October (4) (1986) 1114-1128
28. Wells M.A., Albrecht P., and Ennis F.A. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol 126 March (3) (1981) 1036-1041
29. Justewicz D.M., Doherty P.C., and Webster R.G. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin. J Virol 69 September (9) (1995) 5414-5421
30. Szomolanyi-Tsuda E., and Welsh R.M. T-cell-independent antiviral antibody responses. Curr Opin Immunol 10 August (4) (1998) 431-435
31. Szomolanyi-Tsuda E., Le Q.P., Garcea R.L., and Welsh R.M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 72 August (8) (1998) 6665-6670
32. Bachmann M.F., Hengartner H., and Zinkernagel R.M. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?. Eur J Immunol 25 December (12) (1995) 3445-3451
33. Roman E., Miller E., Harmsen A., Wiley J., Von Andrian U.H., Huston G., et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med 196 October (7) (2002) 957-968
34. Lawrence C.W., Ream R.M., and Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 174 May (9) (2005) 5332-5340
35. Lawrence C.W., and Braciale T.J. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173 July (2) (2004) 1209-1218
36. Topham D.J., Castrucci M.R., Wingo F.S., Belz G.T., and Doherty P.C. The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol 167 December (12) (2001) 6983-6990
37. Turner S.J., Kedzierska K., La Gruta N.L., Webby R., and Doherty P.C. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection. Semin Immunol 16 June (3) (2004) 179-184
38. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 March (5663) (2004) 1529-1531
39. Kopf M., Brombacher F., and Bachmann M.F. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur J Immunol 32 August (8) (2002) 2229-2236
40. Brett I.C., and Johansson B.E. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339 September (2) (2005) 273-280
41. McMichael A.J., Gotch F., Cullen P., Askonas B., and Webster R.G. The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 43 February (2) (1981) 276-284
42. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 March (5102) (1993) 1745-1749
43. Rimmelzwaan G.F., Baars M., van A.G., van B.R., and Osterhaus A.D. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine 20 October (1-2) (2001) 158-163